Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

OBJECTIVE To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of anthrax as a biological weapon against a civilian population. PARTICIPANTS The working group included 21 representatives from staff of major academic medical centers and research, government, military, public health, and emergency management institutions and agencies. EVIDENCE MEDLINE databases were searched from January 1966 to April 1998, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Review of references identified by this search led to identification of relevant references published prior to 1966. In addition, participants identified other unpublished references and sources. CONSENSUS PROCESS The first draft of the consensus statement was a synthesis of information obtained in the formal evidence-gathering process. Members of the working group provided formal written comments which were incorporated into the second draft of the statement. The working group reviewed the second draft on June 12, 1998. No significant disagreements existed and comments were incorporated into a third draft. The fourth and final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members. CONCLUSIONS Specific consensus recommendations are made regarding the diagnosis of anthrax, indications for vaccination, therapy for those exposed, postexposure prophylaxis, decontamination of the environment, and additional research needs.

[1]  P. Jahrling,et al.  Clinical recognition and management of patients exposed to biological warfare agents. , 1997, Clinics in laboratory medicine.

[2]  Robert W Pinner,et al.  Bioterrorism alleging use of anthrax and interim guidelines for management--United States, 1998. , 1999, MMWR. Morbidity and mortality weekly report.

[3]  Ashton B. Carter,et al.  Catastrophic Terrorism: Tackling the New Danger , 1998 .

[4]  Henry Wilde,et al.  Medical Aspects of Chemical and Biological Warfare , 1998 .

[5]  J. D. Malone,et al.  Anthrax as a potential biological warfare agent. , 1998, Archives of internal medicine.

[6]  P. Jahrling,et al.  Clinical recognition and management of patients exposed to biological warfare agents. , 1997, JAMA.

[7]  A. Pomerantsev,et al.  Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection. , 1997, Vaccine.

[8]  J. D. Simon,et al.  Biological terrorism. Preparing to meet the threat. , 1997, JAMA.

[9]  R. Zilinskas,et al.  Iraq's biological weapons. The past as future? , 1997, JAMA.

[10]  T J Cieslak,et al.  Biological warfare : A historical perspective , 1997 .

[11]  A. Tekin,et al.  Acute abdomen due to anthrax , 1997, The British journal of surgery.

[12]  M. Meltzer,et al.  The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? , 1997, Emerging infectious diseases.

[13]  L. Cole,et al.  The specter of biological weapons. , 1996, Scientific American.

[14]  S. Siziya,et al.  Factors associated with human anthrax outbreak in the Chikupo and Ngandu villages of Murewa district in Mashonaland East Province, Zimbabwe. , 1996, The Central African journal of medicine.

[15]  A. Stepanov,et al.  Development of novel vaccines against anthrax in man. , 1996, Journal of biotechnology.

[16]  S. Welkos,et al.  Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys , 1996 .

[17]  D. Dragon,et al.  The ecology of anthrax spores: tough but not invincible. , 1995, The Canadian veterinary journal = La revue veterinaire canadienne.

[18]  M. Salam,et al.  Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission , 1995, The Pediatric infectious disease journal.

[19]  M. Hugh-jones,et al.  The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.

[20]  G. McEvoy,et al.  AHFS Drug Information , 1994 .

[21]  S. Morse,et al.  [1] Recommendations for working with pathogenic bacteria , 1994 .

[22]  J. Ezzell,et al.  Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.

[23]  D H Walker,et al.  Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Friedlander,et al.  Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys. , 1992, The Journal of infectious diseases.

[25]  P. Turnbull,et al.  Anthrax vaccines: past, present and future. , 1991, Vaccine.

[26]  V. De Vos,et al.  The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park. , 1991, The Onderstepoort journal of veterinary research.

[27]  M. Doğanay,et al.  Antimicrobial susceptibility of Bacillus anthracis. , 1991, Scandinavian journal of infectious diseases.

[28]  R. Titball,et al.  The monitoring and detection of Bacillus anthracis in the environment. , 1991, Society for Applied Bacteriology symposium series.

[29]  K. Limpakarnjanarat,et al.  Outbreak of anthrax in Thailand. , 1990, Annals of Tropical Medicine and Parasitology.

[30]  J. Ezzell,et al.  Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand. , 1988, The American journal of tropical medicine and hygiene.

[31]  J. Fierer,et al.  Infectious Diseases and Medical Microbiology , 1985 .

[32]  T. Sirisanthana,et al.  Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with Bacillus anthracis. , 1984, The American journal of tropical medicine and hygiene.

[33]  C. V. Chester,et al.  Emergency Protection from Aerosols , 1981 .

[34]  P. Brachman.  INHALATION ANTHRAX , 1980, Annals of the New York Academy of Sciences.

[35]  K. Vessal,et al.  Radiological changes in inhalation anthrax. A report of radiological and pathological correlation in two cases. , 1975, Clinical radiology.

[36]  A. Kaufmann,et al.  Woolsorters' disease. An experimental model. , 1971, Archives of pathology.

[37]  W. Dutz,et al.  Gastric anthrax with massive ascites , 1970, Gut.

[38]  P. Ud.  Epidemiology of anthrax in wild animals and the control of anthrax epizootics in the Kruger National Park, South Africa. , 1967 .

[39]  J. Walker,et al.  Pathophysiological and biochemical changes in anthrax. , 1967, Federation proceedings.

[40]  P. Brachman,et al.  Industrial inhalation Anthrax. , 1966, Bacteriological reviews.

[41]  W. I. Jones,et al.  Role of the lymphatics in the pathogenesis of anthrax. , 1965, The Journal of infectious diseases.

[42]  M. Ashraf,et al.  ANTHRAX: A CONTINUOUS PROBLEM IN SOUTHWEST IRAN , 1964, The American journal of the medical sciences.

[43]  W. I. Jones,et al.  SUCCESSFUL TREATMENT OF RHESUS MONKEYS FOR SEPTICEMIA ANTHRAX. , 1964, Antimicrobial agents and chemotherapy.

[44]  W S GOCHENOUR,et al.  PATHOLOGY OF EXPERIMENTAL RESPIRATORY ANTHRAX IN MACACA MULATTA. , 1963, British journal of experimental pathology.

[45]  Field Evaluation of a Human Anthrax Vaccine. , 1962, American journal of public health and the nation's health.

[46]  T. Hatch,et al.  Distribution and deposition of inhaled particles in respiratory tract. , 1961, Bacteriological reviews.

[47]  A. Langmuir.  Public health implications of airborne infection: medical aspects. , 1961, Bacteriological reviews.

[48]  Philip S. Brachman,et al.  Bacillus anthracis aerosols in goat hair processing mills. , 1960, American journal of hygiene.

[49]  W. Albrink,et al.  Human inhalation anthrax. A report of three fatal cases. , 1960, The American journal of pathology.

[50]  J. M. Ross.  The pathogenesis of anthrax following the administration of spores by the respiratory route , 1957 .

[51]  D. W. Henderson,et al.  Observations on the prophylaxis of experimental pulmonary anthrax in the monkey , 1956, Journal of Hygiene.

[52]  H. Smith,et al.  Observations on Experimental Anthrax: Demonstration of a Specific Lethal Factor produced in vivo by Bacillus anthracis , 1954, Nature.

[53]  D. W. Henderson,et al.  Studies on respiratory infection: I. The influence of particle size on respiratory infection with anthrax spores , 1953, Journal of Hygiene.

[54]  J. Barnes.  Penicillin and B-anthracis. , 1947, The Journal of pathology and bacteriology.